24 results
Common Causes of the Different Categories of Dizziness #Diagnosis #PrimaryCare #EM #IM #Differential #Dizziness #Vertigo #Disequilibrium
#PrimaryCare #EM ... #IM #Differential ... Lightheadedness #Table ... #NEJM
PCI in Acute MI with Cardiogenic Shock. #EBM #Cardiology #CULPRITSHOCK #PCI #VisualAbstract #NEJM
with Cardiogenic Shock ... #EBM #Cardiology ... VisualAbstract #NEJM
Main types of organ-specific injuries after an electric shock #Diagnosis #Pathophys #EM #Burn #IM #ElectricShock #ElectricalInjury
after an electric shock ... Diagnosis #Pathophys #EM ... #Burn #IM #ElectricShock
Operationalization of New Sepsis and Septic Shock Criteria #Diagnosis #Management #EM #IM #QSofa #Score #Sepsis #SepticShock
Sepsis and Septic Shock ... Diagnosis #Management #EM ... #IM #QSofa #Score
Differential Diagnosis of Jaundice, Presentation Pattern #Diagnosis #EM #IM #GI #Jaundice #Pattern #LFTs #Workup #Table #Differential
Pattern #Diagnosis #EM ... #IM #GI #Jaundice ... #LFTs #Workup #Table
Catecholamine Vasopressor Effect Sites and Indications #Pathophys #Management #EM #IM #PCC #Catecholamine #Comparison #Table #Epi #Norepi
Pathophys #Management #EM ... #IM #PCC #Catecholamine ... #Comparison #Table
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Event Rates of the Primary End Point and Its Components at 30 Days #EBM #Cardiology #CULPRIT-SHOCK
Components at 30 Days #EBM ... Cardiology #CULPRIT-SHOCK ... #CulpritOnly #shock ... #cardiogenic #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock - Event Rates of the
and Cardiogenic Shock ... #EBM #Cardiology ... #CULPRIT-SHOCK ... #CulpritOnly #shock ... #cardiogenic #NEJM